Biocatalysis /

Saved in:
Bibliographic Details
Author / Creator:Bommarius, A. S. (Andreas Sebastian)
Imprint:Weinheim ; Cambridge : Wiley-VCH, c2004.
Description:xxiii, 611 p. ; ill. ; 25 cm.
Language:English
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/5131687
Hidden Bibliographic Details
Varying Form of Title:Biocatalysis: fundamentals and applications
Other authors / contributors:Riebel, B. R. (Bettina R.)
ISBN:3527303448
Notes:Includes bibliographical references (p.591-592) and index.
Table of Contents:
  • Preface
  • Acknowledgments
  • 1. Introduction to Biocatalysis
  • 1.1. Overview: The Status of Biocatalysis at the Turn of the 21st Century
  • 1.1.1. State of Acceptance of Biocatalysis
  • 1.1.2. Current Advantages and Drawbacks of Biocatalysis
  • 1.2. Characteristics of Biocatalysis as a Technology
  • 1.2.1. Contributing Disciplines and Areas of Application
  • 1.2.2. Characteristics of Biocatalytic Transformations
  • 1.2.3. Applications of Biocatalysis in Industry
  • 1.3. Current Penetration of Biocatalysis
  • 1.3.1. The Past: Historical Digest of Enzyme Catalysis
  • 1.3.2. The Present: Status of Biocatalytic Processes
  • 1.4. The Breadth of Biocatalysis
  • 1.4.1. Nomenclature of Enzymes
  • 1.4.2. Biocatalysis and Organic Chemistry, or "Do we Need to Forget our Organic Chemistry?"
  • 2. Characterization of a (Bio-)catalyst
  • 2.1. Characterization of Enzyme Catalysis
  • 2.1.1. Basis of the Activity of Enzymes: What is Enzyme Catalysis?
  • 2.1.2. Development of Enzyme Kinetics from Binding and Catalysis
  • 2.2. Sources and Reasons for the Activity of Enzymes as Catalysts
  • 2.2.1. Chronology of the Most Important Theories of Enzyme Activity
  • 2.2.2. Origin of Enzymatic Activity: Derivation of the Kurz Equation
  • 2.2.3. Consequences of the Kurz Equation
  • 2.2.4. Efficiency of Enzyme Catalysis: Beyond Pauling's Postulate
  • 2.3. Performance Criteria for Catalysts, Processes, and Process Routes
  • 2.3.1. Basic Performance Criteria for a Catalyst: Activity, Selectivity and Stability of Enzymes
  • 2.3.2. Performance Criteria for the Process
  • 2.3.3. Links between Enzyme Reaction Performance Parameters
  • 2.3.4. Performance Criteria for Process Schemes, Atom Economy, and Environmental Quotient
  • 3. Isolation and Preparation of Microorganisms
  • 3.1. Introduction
  • 3.2. Screening of New Enzyme Activities
  • 3.2.1. Growth Rates in Nature
  • 3.2.2. Methods in Microbial Ecology
  • 3.3. Strain Development
  • 3.3.1. Range of Industrial Products from Microorganisms
  • 3.3.2. Strain Improvement
  • 3.4. Extremophiles
  • 3.4.1. Extremophiles in Industry
  • 3.5. Rapid Screening of Biocatalysts
  • 4. Molecular Biology Tools for Biocatalysis
  • 4.1. Molecular Biology Basics: DNA versus Protein Level
  • 4.2. DNA Isolation and Purification
  • 4.2.1. Quantification of DNA/RNA
  • 4.3. Gene Isolation, Detection, and Verification
  • 4.3.1. Polymerase Chain Reaction
  • 4.3.2. Optimization of a PCR Reaction
  • 4.3.3. Special PCR Techniques
  • 4.3.4. Southern Blotting
  • 4.3.5. DNA-Sequencing
  • 4.4. Cloning Techniques
  • 4.4.1. Restriction Mapping
  • 4.4.2. Vectors
  • 4.4.3. Ligation
  • 4.5. (Over)expression of an Enzyme Function in a Host
  • 4.5.1. Choice of an Expression System
  • 4.5.2. Translation and Codon Usage in E. coli
  • 4.5.3. Choice of Vector
  • 4.5.4. Expression of Eukaryotic Genes in Yeasts
  • 5. Enzyme Reaction Engineering
  • 5.1. Kinetic Modeling: Rationale and Purpose
  • 5.2. The Ideal World: Ideal Kinetics and Ideal Reactors
  • 5.2.1. The Classic Case: Michaelis-Menten Equation
  • 5.2.2. Design of Ideal Reactors
  • 5.2.3. Integrated Michaelis-Menten Equation in Ideal Reactors
  • 5.3. Enzymes with Unfavorable Binding: Inhibition
  • 5.3.1. Types of Inhibitors
  • 5.3.2. Integrated Michaelis-Menten Equation for Substrate and Product Inhibition
  • 5.3.3. The KI -[I]50 Relationship: Another Useful Application of Mechanism Elucidation
  • 5.4. Reactor Engineering
  • 5.4.1. Configuration of Enzyme Reactors
  • 5.4.2. Immobilized Enzyme Reactor (Fixed-Bed Reactor with Plug-Flow)
  • 5.4.3. Enzyme Membrane Reactor (Continuous Stirred Tank Reactor, CSTR)
  • 5.4.4. Rules for Choice of Reaction Parameters and Reactors
  • 5.5. Enzyme Reactions with Incomplete Mass Transfer: Influence of Immobilization
  • 5.5.1. External Diffusion (Film Diffusion)
  • 5.5.2. Internal Diffusion (Pore Diffusion)
  • 5.5.3. Methods of Testing for Mass Transfer Limitations
  • 5.5.4. Influence of Mass Transfer on the Reaction Parameters
  • 5.6. Enzymes with Incomplete Stability: Deactivation Kinetics
  • 5.6.1. Resting Stability
  • 5.6.2. Operational Stability
  • 5.6.3. Comparison of Resting and Operational Stability
  • 5.6.4. Strategy for the Addition of Fresh Enzyme to Deactiving Enzyme in Continuous Reactors
  • 5.7. Enzymes with Incomplete Selectivity: E-Value and its Optimization
  • 5.7.1. Derivation of the E-Value
  • 5.7.2. Optimization of Separation of Racemates by Choice of Degree of Conversion
  • 5.7.3. Optimization of Enantiomeric Ratio E by Choice of Temperature
  • 6. Applications of Enzymes as Bulk Actives: Detergents, Textiles, Pulp and Paper, Animal Feed
  • 6.1. Application of Enzymes in Laundry Detergents
  • 6.1.1. Overview
  • 6.1.2. Proteases against Blood and Egg Stains
  • 6.1.3. Lipases against Grease Stains
  • 6.1.4. Amylases against Grass and Starch Dirt
  • 6.1.5. Cellulases
  • 6.1.6. Bleach Enzymes
  • 6.2. Enzymes in the Textile Industry: Stone-washed Denims, Shiny Cotton Surfaces
  • 6.2.1. Build-up and Mode of Action of Enzymes for the Textile Industry
  • 6.2.2. Cellulases: the Shinier Look
  • 6.2.3. Stonewashing: Biostoning of Denim: the Worn Look
  • 6.2.4. Peroxidases
  • 6.3. Enzymes in the Pulp and Paper Industry: Bleaching of Pulp with Xylanases or Laccases
  • 6.3.1. Introduction
  • 6.3.2. Wood
  • 6.3.3. Papermaking: Kraft Pulping Process
  • 6.3.4. Research on Enzymes in the Pulp and Paper Industry
  • 6.4. Phytase for Animal Feed: Utilization of Phosphorus
  • 6.4.1. The Farm Animal Business and the Environment
  • 6.4.2. Phytase
  • 6.4.3. Efficacy of Phytase: Reduction of Phosphorus
  • 6.4.4. Efficacy of Phytase: Effect on Other Nutrients
  • 7. Application of Enzymes as Catalysts: Basic Chemicals, Fine Chemicals, Food, Crop Protection, Bulk Pharmaceuticals
  • 7.1. Enzymes as Catalysts in Processes towards Basic Chemicals
  • 7.1.1. Nitrile Hydratase: Acrylamide from Acrylonitrile, Nicotinamide from 3-Cyanopyridine, and 5-Cyanovaleramide from Adiponitrile
  • 7.1.2. Nitrilase: 1,5-Dimethyl-2-piperidone from 2-Methylglutaronitrile
  • 7.1.3. Toluene Dioxygenase: Indigo or Prostaglandins from Substituted Benzenes via cis-Dihydrodiols
  • 7.1.4. Oxynitrilase (Hydroxy Nitrile Lyase, HNL): Cyanohydrins from Aldehydes
  • 7.2. Enzymes as Catalysts in the Fine Chemicals Industry
  • 7.2.1. Chirality, and the Cahn-Ingold-Prelog and Pfeiffer Rules
  • 7.2.2. Enantiomerically Pure Amino Acids
  • 7.2.3. Enantiomerically Pure Hydroxy Acids, Alcohols, and Amines
  • 7.3. Enzymes as Catalysts in the Food Industry
  • 7.3.1. HFCS with Glucose Isomerase (GI)
  • 7.3.2. AspartameO, Artificial Sweetener through Enzymatic Peptide Synthesis
  • 7.3.3. Lactose Hydrolysis
  • 7.3.4. "Nutraceuticals": L-Carnitine as a Nutrient for Athletes and Convalescents (Lonza)
  • 7.3.5. Decarboxylases for Improving the Taste of Beer
  • 7.4. Enzymes as Catalysts towards Crop Protection Chemicals
  • 7.4.1. Intermediate for Herbicides: (R)-2-(4-Hydroxyphenoxypropionic acid (BASF, Germany)
  • 7.4.2. Applications of Transaminases towards Crop Protection Agents: L-Phosphinothricin and (S)-MOIPA
  • 7.5. Enzymes for Large-Scale Pharma Intermediates
  • 7.5.1. Penicillin G (or V) Amidase (PGA, PVA): [beta]-Lactam Precursors, Semi-synthetic [beta]-Lactams
  • 7.5.2. Ephedrine
  • 8. Biotechnological Processing Steps for Enzyme Manufacture
  • 8.1. Introduction to Protein Isolation and Purification
  • 8.2. Basics of Fermentation
  • 8.2.1. Medium Requirements
  • 8.2.2. Sterilization
  • 8.2.3. Phases of a Fermentation
  • 8.2.4. Modeling of a Fermentation
  • 8.2.5. Growth Models
  • 8.2.6. Fed-Batch Culture
  • 8.3. Fermentation and its Main Challenge: Transfer of Oxygen
  • 8.3.1. Determination of Required Oxygen Demand of the Cells
  • 8.3.2. Calculation of Oxygen Transport in the Fermenter Solution
  • 8.3.3. Determination of k[subscript L], a, and k[subscript L]a
  • 8.4. Downstream Processing: Crude Purification of Proteins
  • 8.4.1. Separation (Centrifugation)
  • 8.4.2. Homogenization
  • 8.4.3. Precipitation
  • 8.4.4. Aqueous Two-Phase Extraction
  • 8.5. Downstream Processing: Concentration and Purification of Proteins
  • 8.5.1. Dialysis (Ultrafiltration) (adapted in part from Blanch, 1997)
  • 8.5.2. Chromatography
  • 8.5.3. Drying: Spray Drying, Lyophilization, Stabilization for Storage
  • 8.6. Examples of Biocatalyst Purification
  • 8.6.1. Example 1: Alcohol Dehydrogenase [(R)-ADH from L. brevis (Riebel, 1997)]
  • 8.6.2. Example 2: l-Amino Acid Oxidase from Rhodococcus opacus (Geueke 2002a,b)
  • 8.6.3. Example 3: Xylose Isomerase from Thermoanaerobium Strain JW/SL-YS 489
  • 9. Methods for the Investigation of Proteins
  • 9.1. Relevance of Enzyme Mechanism
  • 9.2. Experimental Methods for the Investigation of an Enzyme Mechanism
  • 9.2.1. Distribution of Products (Curtin-Hammett Principle)
  • 9.2.2. Stationary Methods of Enzyme Kinetics
  • 9.2.3. Linear Free Enthalpy Relationships (LFERs): Bronsted and Hammett Effects
  • 9.2.4. Kinetic Isotope Effects
  • 9.2.5. Non-stationary Methods of Enzyme Kinetics: Titration of Active Sites
  • 9.2.6. Utility of the Elucidation of Mechanism: Transition-State Analog Inhibitors
  • 9.3. Methods of Enzyme Determination
  • 9.3.1. Quantification of Protein
  • 9.3.2. Isoelectric Point Determination
  • 9.3.3. Molecular Mass Determination of Protein Monomer: SDS-PAGE
  • 9.3.4. Mass of an Oligomeric Protein: Size Exclusion Chromatography (SEC)
  • 9.3.5. Mass Determination: Mass Spectrometry (MS) (after Kellner, Lottspeich, Meyer)
  • 9.3.6. Determination of Amino Acid Sequence by Tryptic Degradation, or Acid, Chemical or Enzymatic Digestion
  • 9.4. Enzymatic Mechanisms: General Acid-Base Catalysis
  • 9.4.1. Carbonic Anhydrase II
  • 9.4.2. Vanadium Haloperoxidase
  • 9.5. Nucleophilic Catalysis
  • 9.5.1. Serine Proteases
  • 9.5.2. Cysteine in Nucleophilic Attack
  • 9.5.3. Lipase, Another Catalytic Triad Mechanism
  • 9.5.4. Metalloproteases
  • 9.6. Electrophilic catalysis
  • 9.6.1. Utilization of Metal Ions: ADH, a Different Catalytic Triad
  • 9.6.2. Formation of a Schiff Base, Part I: Acetoacetate Decarboxylase, Aldolase
  • 9.6.3. Formation of a Schiff Base with Pyridoxal Phosphate (PLP): Alanine Racemase, Amino Acid Transferase
  • 9.6.4. Utilization of Thiamine Pyrophosphate (TPP): Transketolase
  • 10. Protein Engineering
  • 10.1. Introduction: Elements of Protein Engineering
  • 10.2. Methods of Protein Engineering
  • 10.2.1. Fusion PCR
  • 10.2.2. Kunkel Method
  • 10.2.3. Site-Specific Mutagenesis Using the QuikChange Kit from Stratagene
  • 10.2.4. Combined Chain Reaction (CCR)
  • 10.3. Glucose (Xylose) Isomerase (GI) and Glycoamylase: Enhancement of Thermostability
  • 10.3.1. Enhancement of Thermostability in Glucose Isomerase (GI)
  • 10.3.2. Resolving the Reaction Mechanism of Glucose Isomerase (GI): Diffusion-Limited Glucose Isomerase?
  • 10.4. Enhancement of Stability of Proteases against Oxidation and Thermal Deactivation
  • 10.4.1. Enhancement of Oxidation Stability of Subtilisin
  • 10.4.2. Thermostability of Subtilisin
  • 10.5. Creating New Enzymes with Protein Engineering
  • 10.5.1. Redesign of a Lactate Dehydrogenase
  • 10.5.2. Synthetic Peroxidases
  • 10.6. Dehydrogenases, Changing Cofactor Specificity
  • 10.7. Oxygenases
  • 10.8. Change of Enantioselectivity with Site-Specific Mutagenesis
  • 10.9. Techniques Bridging Different Protein Engineering Techniques
  • 10.9.1. Chemically Modified Mutants, a Marriage of Chemical Modification and Protein Engineering
  • 10.9.2. Expansion of Substrate Specificity with Protein Engineering and Directed Evolution
  • 11. Applications of Recombinant DNA Technology: Directed Evolution
  • 11.1. Background of Evolvability of Proteins
  • 11.1.1. Purpose of Directed Evolution
  • 11.1.2. Evolution and Probability
  • 11.1.3. Evolution: Conservation of Essential Components of Structure
  • 11.2. Process steps in Directed Evolution: Creating Diversity and Checking for Hits
  • 11.2.1. Creation of Diversity in a DNA Library
  • 11.2.2. Testing for Positive Hits: Screening or Selection
  • 11.3. Experimental Protocols for Directed Evolution
  • 11.3.1. Creating Diversity: Mutagenesis Methods
  • 11.3.2. Creating Diversity: Recombination Methods
  • 11.3.3. Checking for Hits: Screening Assays
  • 11.3.4. Checking for Hits: Selection Procedures
  • 11.3.5. Additional Techniques of Directed Evolution
  • 11.4. Successful Examples of the Application of Directed Evolution
  • 11.4.1. Application of Error-prone PCR: Activation of Subtilisin in DMF
  • 11.4.2. Application of DNA Shuffling: Recombination of p-Nitrobenzyl Esterase Genes
  • 11.4.3. Enhancement of Thermostability: p-Nitrophenyl Esterase
  • 11.4.4. Selection instead of Screening: Creation of a Monomeric Chorismate Mutase
  • 11.4.5. Improvement of Enantioselectivity: Pseudomonas aeruginosa Lipase
  • 11.4.6. Inversion of Enantioselectivity: Hydantoinase
  • 11.4.7. Redesign of an Enzyme's Active Site: KDPG Aldolase
  • 11.5. Comparison of Directed Evolution Techniques
  • 11.5.1. Comparison of Error-Prone PCR and DNA Shuffling: Increased Resistance against Antibiotics
  • 11.5.2. Protein Engineering in Comparison with Directed Evolution: Aminotransferases
  • 11.5.3. Directed Evolution of a Pathway: Carotenoids
  • 12. Biocatalysis in Non-conventional Media
  • 12.1. Enzymes in Organic Solvents
  • 12.2. Evidence for the Perceived Advantages of Biocatalysts in Organic Media
  • 12.2.1. Advantage 1: Enhancement of Solubility of Reactants
  • 12.2.2. Advantage 2: Shift of Equilibria in Organic Media
  • 12.2.3. Advantage 3: Easier Separation
  • 12.2.4. Advantage 4: Enhanced Stability of Enzymes in Organic Solvents
  • 12.2.5. Advantage 5: Altered Selectivity of Enzymes in Organic Solvents
  • 12.3. State of Knowledge of Functioning of Enzymes in Solvents
  • 12.3.1. Range of Enzymes, Reactions, and Solvents
  • 12.3.2. The Importance of Water in Enzyme Reactions in Organic Solvents
  • 12.3.3. Physical Organic Chemistry of Enzymes in Organic Solvents
  • 12.3.4. Correlation of Enzyme Performance with Solvent Parameters
  • 12.4. Optimal Handling of Enzymes in Organic Solvents
  • 12.4.1. Enzyme Memory in Organic Solvents
  • 12.4.2. Low Activity in Organic Solvents Compared to Water
  • 12.4.3. Enhancement of Selectivity of Enzymes in Organic Solvents
  • 12.5. Novel Reaction Media for Biocatalytic Transformations
  • 12.5.1. Substrate as Solvent (Neat Substrates): Acrylamide from Acrylonitrile with Nitrile Hydratase
  • 12.5.2. Supercritical Solvents
  • 12.5.3. Ionic Liquids
  • 12.5.4. Emulsions [Manufacture of Phosphatidylglycerol (PG)]
  • 12.5.5. Microemulsions
  • 12.5.6. Liquid Crystals
  • 12.5.7. Ice-Water Mixtures
  • 12.5.8. High-Density Eutectic Suspensions
  • 12.5.9. High-Density Salt Suspensions
  • 12.5.10. Solid-to-Solid Syntheses
  • 12.6. Solvent as a Parameter for Reaction Optimization ("Medium Engineering")
  • 12.6.1. Change of Substrate Specificity with Change of ReactionM: Specificity of Serine Proteases
  • 12.6.2. Change of Regioselectivity by Organic Solvent Medium
  • 12.6.3. Solvent Control of Enantiospecificity of Nifedipines
  • 13. Pharmaceutical Applications of Biocatalysis
  • 13.1. Enzyme Inhibition for the Fight against Disease
  • 13.1.1. Introduction
  • 13.1.2. Procedure for the Development of Pharmacologically Active Compounds
  • 13.1.3. Process for the Registration of New Drugs
  • 13.1.4. Chiral versus Non-chiral Drugs
  • 13.2. Enzyme Cascades and Biology of Diseases
  • 13.2.1. [beta]-Lactam Antibiotics
  • 13.2.2. Inhibition of Cholesterol Biosynthesis (in part after Suckling, 1990)
  • 13.2.3. Pulmonary Emphysema, Osteoarthritis: Human Leucocyte Elastase (HLE)
  • 13.2.4. AIDS: Reverse Transcriptase and HIV Protease Inhibitors
  • 13.3. Pharmaceutical Applications of Biocatalysis
  • 13.3.1. Antiinfectives (see also Chapter 7, Section 7.5.1)
  • 13.3.2. Anticholesterol Drugs
  • 13.3.3. Anti-AIDS Drugs
  • 13.3.4. High Blood Pressure Treatment
  • 13.4. Applications of Specific Biocatalytic Reactions in Pharma
  • 13.4.1. Reduction of Keto Compounds with Whole Cells
  • 13.4.2. Applications of Pen G Acylase in Pharma
  • 13.4.3. Applications of Lipases and Esterases in Pharma
  • 14. Bioinformatics
  • 14.1. Starting Point: from Consequence (Function) to Sequence
  • 14.1.1. Conventional Path: from Function to Sequence
  • 14.1.2. Novel Path: from Sequence to Consequence (Function)
  • 14.2. Bioinformatics: What is it, Why do we Need it, and Why Now? (NCBI Homepage)
  • 14.2.1. What is Bioinformatics?
  • 14.2.2. Why do we Need Bioinformatics?
  • 14.2.3. Why Bioinformatics Now?
  • 14.3. Tools of Bioinformatics: Databases, Alignments, Structural Mapping
  • 14.3.1. Available Databases
  • 14.3.2. Protein Data Bank (PDB)
  • 14.3.3. Protein Explorer
  • 14.3.4. ExPASy Server: Roche Applied Science Biochemical Pathways
  • 14.3.5. GenBank
  • 14.3.6. SwissProt
  • 14.3.7. Information on an Enzyme: the Example of dehydrogenases
  • 14.4. Applied Bioinformatics Tools, with Examples
  • 14.4.1. BLAST
  • 14.4.2. Aligning Several Protein Sequences using ClustalW
  • 14.4.3. Task: Whole Genome Analysis
  • 14.4.4. Phylogenetic Tree
  • 14.5. Bioinformatics for Structural Information on Enzymes
  • 14.5.1. The Status of Predicting Protein Three-Dimensional Structure
  • 14.6. Conclusion and Outlook
  • 15. Systems Biology for Biocatalysis
  • 15.1. Introduction to Systems Biology
  • 15.1.1. Systems Approach versus Reductionism
  • 15.1.2. Completion of Genomes: Man, Earthworm, and Others
  • 15.2. Genomics, Proteomics, and other -omics
  • 15.2.1. Genomics
  • 15.2.2. Proteomics
  • 15.3. Technologies for Systems Biology
  • 15.3.1. Two-Dimensional Gel Electrophoresis (2D PAGE)
  • 15.3.2. Mass Spectroscopy
  • 15.3.3. DNA Microarrays
  • 15.3.4. Protein Microarrays
  • 15.3.5. Applications of Genomics and Proteomics in Biocatalysis
  • 15.4. Metabolic Engineering
  • 15.4.1. Concepts of Metabolic Engineering
  • 15.4.2. Examples of Metabolic Engineering
  • 16. Evolution of Biocatalytic Function
  • 16.1. Introduction
  • 16.1.2. Congruence of Sequence, Function, Structure, and Mechanism
  • 16.2. Search Characteristics for Relatedness in Proteins
  • 16.2.1. Classification of Relatedness of Proteins: the -log Family
  • 16.2.2. Classification into Protein Families
  • 16.2.3. Dominance of Different Mechanisms
  • 16.3. Evolution of New Function in Nature
  • 16.3.1. Dual-Functionality Proteins
  • 16.3.2. Gene Duplication
  • 16.3.3. Horizontal Gene Transfer (HGT)
  • 16.3.4. Circular Permutation
  • 16.4. [alpha]/[beta]-Barrel Proteins as a Model for the Investigation of Evolution
  • 16.4.1. Why Study [alpha]/[beta]-Barrel Proteins?
  • 16.4.2. Example of Gene Duplication: Mandelate and a-Ketoadipate Pathways
  • 16.4.3. Exchange of Function in the Aromatic Biosynthesis Pathways: Trp and His Pathways
  • 17. Stability of Proteins
  • 17.1. Summary: Protein Folding, First-Order Decay, Arrhenius Law
  • 17.1.1. The Protein Folding Problem
  • 17.1.2. Why do Proteins Fold?
  • 17.2. Two-State Model: Thermodynamic Stability of Proteins (Unfolding)
  • 17.2.1. Protein Unfolding and Deactivation
  • 17.2.2. Thermodynamics of Proteins
  • 17.3. Three-State Model: Lumry-Eyring Equation
  • 17.3.1. Enzyme Deactivation
  • 17.3.2. Empirical Deactivation Model
  • 17.4. Four-State Model: Protein Aggregation
  • 17.4.1. Folding, Deactivation, and Aggregation
  • 17.4.2. Model to Account for Competition between Folding and Inclusion Body Formation
  • 17.5. Causes of Instability of Proteins: [Delta]G [less than sign] 0, [gamma](t), A
  • 17.5.1. Thermal Inactivation
  • 17.5.2. Deactivation under the Influence of Stirring
  • 17.5.3. Deactivation under the Influence of Gas Bubbles
  • 17.5.4. Deactivation under the Influence of Aqueous/Organic Interfaces
  • 17.5.5. Deactivation under the Influence of Salts and Solvents
  • 17.6. Biotechnological Relevance of Protein Folding: Inclusion Bodies
  • 17.7. Summary: Stabilization of Proteins
  • 17.7.1. Correlation between Stability and Structure
  • 18. Artificial Enzymes
  • 18.1. Catalytic Antibodies
  • 18.1.1. Principle of Catalytic Antibodies: Connection between Chemistry and Immunology
  • 18.1.2. Test Reaction Selection, Haptens, Mechanisms, Stabilization
  • 18.1.3. Breadth of Reactions Catalyzed by Antibodies
  • 18.2. Other Proteinaceous Catalysts: Ribozymes and Enzyme Mimics
  • 18.2.1. Ribozymes: RNA World before Protein World?
  • 18.2.2. Proteinaceous Enzyme Mimics
  • 18.3. Design of Novel Enzyme Activity: Enzyme Models (Synzymes)
  • 18.3.1. Introduction
  • 18.3.2. Enzyme Models on the Basis of the Binding Step: Diels-Alder Reaction
  • 18.3.3. Enzyme Models with Binding and Catalytic Effects
  • 18.4. Heterogenized/Immobilized Chiral Chemical Catalysts
  • 18.4.1. Overview of Different Approaches
  • 18.4.2. Immobilization with Polyamino Acids as Chiral Polymer Catalysts
  • 18.4.3. Immobilization on Resins or other Insoluble Carriers
  • 18.4.4. Heterogenization with Dendrimers
  • 18.4.5. Retention of Heterogenized Chiral Chemical Catalysts in a Membrane Reactor
  • 18.4.6. Recovery of Organometallic Catalysts by Phase Change: Liquid-Liquid Extraction
  • 18.5. Tandem Enzyme Organometallic Catalysts
  • 19. Design of Biocatalytic Processes
  • 19.1. Design of Enzyme Processes: High-Fructose Corn Syrup (HFCS)
  • 19.1.1. Manufacture of HFCS from Glucose with Glucose Isomerase (GI): Process Details
  • 19.1.2. Mathematical Model for the Description of the Enzyme Kinetics of Glucose Isomerase (GI)
  • 19.1.3. Evaluation of the Model of the GI Reaction in the Fixed-Bed Reactor
  • 19.1.4. Productivity of a Fixed-Bed Enzyme Reactor
  • 19.2. Processing of Fine Chemicals or Pharmaceutical Intermediates in an Enzyme Membrane Reactor
  • 19.2.1. Introduction
  • 19.2.2. Determination of Process Parameters of a Membrane Reactor
  • 19.2.3. Large-Scale Applications of Membrane Reactors
  • 19.3. Production of Enantiomerically Pure Hydrophobic Alcohols: Comparison of Different Process Routes and Reactor Configurations
  • 19.3.1. Isolated Enzyme Approach
  • 19.3.2. Whole-Cell Approach
  • 19.3.3. Organometallic Catalyst Approach
  • 19.3.4. Comparison of Different Catalytic Reduction Strategies
  • 20. Comparison of Biological and Chemical Catalysts for Novel Processes
  • 20.1. Criteria for the Judgment of (Bio-)catalytic Processes
  • 20.1.1. Discussion: Jacobsen's Five Criteria
  • 20.1.2. Comment on Jabobsen's Five Criteria
  • 20.2. Position of Biocatalysis in Comparison to Chemical Catalysts for Novel Processes
  • 20.2.1. Conditions and Framework for Processes of the Future
  • 20.2.2. Ibuprofen (Painkiller)
  • 20.2.3. Indigo (Blue Dye)
  • 20.2.4. Menthol (Peppermint Flavoring Agent)
  • 20.2.5. Ascorbic Acid (Vitamin C)
  • 20.3. Pathway Engineering through Metabolic Engineering
  • 20.3.1. Pathway Engineering for Basic Chemicals: 1,3-Propanediol
  • 20.3.2. Pathway Engineering for Pharmaceutical Intermediates: cis-Aminoindanol
  • Index